Coevolution-Driven Method for Efficiently Simulating Conformational Changes in Proteins Reveals Molecular Details of Ligand Effects in the β2AR Receptor.
Journal
The journal of physical chemistry. B
ISSN: 1520-5207
Titre abrégé: J Phys Chem B
Pays: United States
ID NLM: 101157530
Informations de publication
Date de publication:
23 Nov 2023
23 Nov 2023
Historique:
medline:
24
11
2023
pubmed:
10
11
2023
entrez:
10
11
2023
Statut:
ppublish
Résumé
With the advent of AI-powered structure prediction, the scientific community is inching closer to solving protein folding. An unresolved enigma, however, is to accurately, reliably, and deterministically predict alternative conformational states that are crucial for the function of, e.g., transporters, receptors, or ion channels where conformational cycling is innately coupled to protein function. Accurately discovering and exploring all conformational states of membrane proteins has been challenging due to the need to retain atomistic detail while enhancing the sampling along interesting degrees of freedom. The challenges include but are not limited to finding which degrees of freedom are relevant, how to accelerate the sampling along them, and then quantifying the populations of each micro- and macrostate. In this work, we present a methodology that finds relevant degrees of freedom by combining evolution and physics through machine learning and apply it to the conformational sampling of the β2 adrenergic receptor. In addition to predicting new conformations that are beyond the training set, we have computed free energy surfaces associated with the protein's conformational landscape. We then show that the methodology is able to quantitatively predict the effect of an array of ligands on the β2 adrenergic receptor activation through the discovery of new metastable states not present in the training set. Lastly, we also stake out the structural determinants of activation and inactivation pathway signaling through different ligands and compare them to functional experiments to validate our methodology and potentially gain further insights into the activation mechanism of the β2 adrenergic receptor.
Identifiants
pubmed: 37947090
doi: 10.1021/acs.jpcb.3c04897
pmc: PMC10683026
doi:
Substances chimiques
Ligands
0
Membrane Proteins
0
Receptors, Adrenergic
0
Receptors, Adrenergic, beta-2
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9891-9904Références
Molecules. 2023 Apr 08;28(8):
pubmed: 37110543
Nature. 2017 Jul 6;547(7661):68-73
pubmed: 28607487
J Chem Phys. 2018 Aug 21;149(7):072301
pubmed: 30134694
J Chem Inf Model. 2021 Dec 27;61(12):6024-6037
pubmed: 34780174
Chem Rev. 2021 May 12;121(9):5289-5335
pubmed: 33886296
Nat Struct Mol Biol. 2021 Nov;28(11):879-888
pubmed: 34759375
Structure. 2008 Jun;16(6):897-905
pubmed: 18547522
Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18684-9
pubmed: 22031696
Elife. 2022 Mar 03;11:
pubmed: 35238773
J Biol Chem. 2020 Sep 18;295(38):13239-13249
pubmed: 32723870
J Phys Chem B. 2022 Mar 10;126(9):1917-1932
pubmed: 35196859
Biochem Biophys Res Commun. 2022 Feb 12;592:67-73
pubmed: 35032834
Biochem J. 2022 Jan 28;479(2):145-159
pubmed: 35050326
Front Mol Biosci. 2019 Nov 05;6:117
pubmed: 31750315
Physiology (Bethesda). 2010 Oct;25(5):293-303
pubmed: 20940434
Phys Rev Lett. 2001 Mar 5;86(10):2050-3
pubmed: 11289852
Phys Chem Chem Phys. 2014 Apr 14;16(14):6398-406
pubmed: 24445284
Cell. 2013 Jan 31;152(3):532-42
pubmed: 23374348
Signal Transduct Target Ther. 2021 Jan 8;6(1):7
pubmed: 33414387
Elife. 2021 Jan 28;10:
pubmed: 33506760
Mol Cells. 2015;38(2):105-11
pubmed: 25537861
Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):15674-9
pubmed: 24009338
Science. 2012 Mar 2;335(6072):1106-10
pubmed: 22267580
J Pharmacol Exp Ther. 2007 May;321(2):642-7
pubmed: 17293563
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
J Am Chem Soc. 2013 Jun 26;135(25):9465-74
pubmed: 23721409
Nature. 2011 Jan 13;469(7329):241-4
pubmed: 21228877
Science. 2007 Nov 23;318(5854):1258-65
pubmed: 17962520
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
Mol Pharmacol. 2011 Sep;80(3):367-77
pubmed: 21610196
J Chem Inf Model. 2012 Dec 21;52(12):3144-54
pubmed: 23146088
J Chem Theory Comput. 2019 Dec 10;15(12):6752-6759
pubmed: 31647864
Elife. 2014 May 01;3:e02030
pubmed: 24842992
Nucleic Acids Res. 2021 Jan 8;49(D1):D412-D419
pubmed: 33125078
J Chem Phys. 2014 Jul 28;141(4):044110
pubmed: 25084884
Elife. 2023 Jul 05;12:
pubmed: 37405832
Biochemistry. 2013 Aug 20;52(33):5593-603
pubmed: 23879802
Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14414-9
pubmed: 15385676
Nat Commun. 2012;3:1045
pubmed: 22948827
Elife. 2023 Jul 05;12:
pubmed: 37405846
Br J Pharmacol. 2010 Jul;160(5):1048-61
pubmed: 20590599
Nature. 2013 Oct 24;502(7472):575-579
pubmed: 24056936
Eur J Pharmacol. 2001 Jun 15;421(3):141-7
pubmed: 11516429
Nat Protoc. 2021 Dec;16(12):5634-5651
pubmed: 34759384
PLoS Comput Biol. 2011 Oct;7(10):e1002193
pubmed: 22022248
Nat Methods. 2017 Jan;14(1):71-73
pubmed: 27819658
Annu Rev Biochem. 2018 Jun 20;87:897-919
pubmed: 29925258
PLoS One. 2016 May 17;11(5):e0155816
pubmed: 27187591
Elife. 2020 Oct 21;9:
pubmed: 33084570